CoChat

Myostatin Gene Inactivation Prevents Skeletal Muscle Wasting in Cancer

Gallot, Yann S., Durieux, Anne-Cécile, Castells, Josiane, Desgeorges, Marine M., Vernus, Barbara, Plantureux, Léa, Rémond, Didier, Jahnke, Vanessa E., Lefai, Etienne, Dardevet, Dominique, Nemoz, Georges, Schaeffer, Laurent, Bonnieu, Anne, Freyssenet, Damien G. · 2014 · Cancer Research
Cited by 117

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Cachexia is a muscle-wasting syndrome that contributes significantly to morbidity and mortality of many patients with advanced cancers. However, little is understood about how the severe loss of skeletal muscle characterizing this condition occurs. In the current study, we tested the hypothesis that the muscle protein myostatin is involved in mediating the pathogenesis of cachexia-induced muscle wasting in tumor-bearing mice. Myostatin gene inactivation prevented the severe loss of skeletal muscle mass induced in mice engrafted with Lewis lung carcinoma (LLC) cells or in ApcMin/+ mice, an established model of colorectal cancer and cachexia. Mechanistically, myostatin loss attenuated the activation of muscle fiber proteolytic pathways by inhibiting the expression of atrophy-related genes, MuRF1 and MAFbx/Atrogin-1, along with autophagy-related genes. Notably, myostatin loss also impeded the growth of LLC tumors, the number and the size of intestinal polyps in ApcMin/+ mice, thus strongly increasing survival in both models. Gene expression analysis in the LLC model showed this phenotype to be associated with reduced expression of genes involved in tumor metabolism, activin signaling, and apoptosis. Taken together, our results reveal an essential role for myostatin in the pathogenesis of cancer cachexia and link this condition to tumor growth, with implications for furthering understanding of cancer as a systemic disease. Cancer Res; 74(24); 7344–56. ©2014 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-14-0057

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 117

Metadata

Authors
Gallot, Y. S., Durieux, A.-C., Castells, J., Desgeorges, M. M., Vernus, B., Plantureux, L., Rémond, D., Jahnke, V. E., Lefai, E., Dardevet, D., Nemoz, G., Schaeffer, L., Bonnieu, A., & Freyssenet, D. G.
Venue
Cancer Research
Published
2014-12-14
Volume
74
Issue
24
Pages
7344-7356
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W1983411014
Cited by
117
References
18
FWCI
3.04
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Myostatin Gene Inactivation Prevents Skeletal Muscle Wasting in Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-14-0057
The paper
Gallot, Y. S., Durieux, A.-C., Castells, J., Desgeorges, M. M., Vernus, B., Plantureux, L., Rémond, D., Jahnke, V. E., Lefai, E., Dardevet, D., Nemoz, G., Schaeffer, L., Bonnieu, A., & Freyssenet, D. G. (2014). Myostatin Gene Inactivation Prevents Skeletal Muscle Wasting in Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-14-0057

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.